A detailed history of Fort Point Capital Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 8,627 shares of PFE stock, worth $241,383. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,627
Holding current value
$241,383
% of portfolio
0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $223,353 - $256,480
8,627 New
8,627 $239,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $20,010 - $23,151
-554 Reduced 5.27%
9,955 $365,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $43,604 - $56,766
-1,107 Reduced 9.53%
10,509 $428,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $83,500 - $109,000
-2,000 Reduced 14.69%
11,616 $595,000
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $126,510 - $154,437
2,891 Added 26.96%
13,616 $596,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $7,537 - $8,937
162 Added 1.53%
10,725 $562,000
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $71,964 - $89,173
1,573 Added 17.5%
10,563 $547,000
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $28,103 - $36,100
-716 Reduced 7.38%
8,990 $387,000
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $8,977 - $10,170
250 Added 2.64%
9,706 $380,000
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $316,681 - $357,153
9,456 New
9,456 $343,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $150,070 - $214,418
-5,552 Closed
0 $0
Q4 2019

Feb 03, 2020

SELL
$32.92 - $37.36 $6,584 - $7,472
-200 Reduced 3.48%
5,552 $218,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $186,882 - $242,331
5,752 New
5,752 $207,000
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $473,887 - $520,644
-12,637 Closed
0 $0
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $1,808 - $2,061
-47 Reduced 0.37%
12,637 $552,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $100,273 - $121,625
2,909 Added 29.76%
12,684 $559,000
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $117,969 - $125,767
-3,577 Reduced 26.79%
9,775 $355,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $24,730 - $28,690
775 Added 6.16%
13,352 $474,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $205,214 - $217,739
6,170 Added 96.3%
12,577 $456,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $198,617 - $218,799
6,407
6,407 $229,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.